Pages that link to "Q37935268"
Jump to navigation
Jump to search
The following pages link to New perspectives in pharmacological treatment of mild persistent asthma (Q37935268):
Displaying 32 items.
- Vilanterol and fluticasone for asthma (Q24197900) (← links)
- The asthma-COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease? (Q26745760) (← links)
- Fractionated breath condensate sampling: H2O2 concentrations of the alveolar fraction may be related to asthma control in children (Q30318183) (← links)
- Serum based diagnosis of asthma using Raman spectroscopy: an early phase pilot study. (Q30355742) (← links)
- Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation (Q33632763) (← links)
- Parameters of lung inflammation in asthmatic as compared to healthy children in a contaminated city (Q33938384) (← links)
- Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma (Q34016209) (← links)
- Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity. (Q34434995) (← links)
- Age-of-asthma onset as a determinant of different asthma phenotypes in adults: a systematic review and meta-analysis of the literature. (Q34458002) (← links)
- Vilanterol and fluticasone furoate for asthma. (Q34539126) (← links)
- Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing (Q35015651) (← links)
- Altered Epithelial Gene Expression in Peripheral Airways of Severe Asthma (Q36237870) (← links)
- New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma (Q36252920) (← links)
- The risk and outcomes of pneumonia in patients on inhaled corticosteroids (Q37364624) (← links)
- 5-Lipoxygenase inhibitors: a review of recent patents (2010-2012). (Q38100199) (← links)
- Volatile organic compounds in asthma diagnosis: a systematic review and meta-analysis. (Q38609780) (← links)
- Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma (Q38707759) (← links)
- Investigational prostaglandin D2 receptor antagonists for airway inflammation (Q38812321) (← links)
- The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review. (Q38827675) (← links)
- Investigation into the Role of PI3K and JAK3 Kinase Inhibitors in Murine Models of Asthma (Q38908177) (← links)
- Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma (Q38947467) (← links)
- Inflammatory biomarkers for asthma endotyping and consequent personalized therapy. (Q39202765) (← links)
- Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma (Q39847612) (← links)
- Allergen immunotherapy: how to balance the different views from pulmonologists and allergists? (Q42666135) (← links)
- A composite of exhaled LTB4 , LXA4 , FeNO, and FEV1 as an "asthma classification ratio" characterizes childhood asthma. (Q46301404) (← links)
- Biologic agents for severe asthma patients: clinical perspectives and implications. (Q47576873) (← links)
- The effect of allergen-induced bronchoconstriction on concentration of 5-oxo-ETE in exhaled breath condensate of house dust mite-allergic patients (Q47815361) (← links)
- Montelukast versus Dexamethasone Treatment in a Guinea Pig Model of Chronic Pulmonary Neutrophilic Inflammation. (Q51557440) (← links)
- Hydrogen peroxide content and pH of expired breath condensate from patients with asthma and COPD. (Q54792795) (← links)
- iNOS Inhibition Reduces Lung Mechanical Alterations and Remodeling Induced by Particulate Matter in Mice (Q64109609) (← links)
- A Guinea Pig Model of Airway Smooth Muscle Hyperreactivity Induced by Chronic Allergic Lung Inflammation: Contribution of Epithelium and Oxidative Stress (Q64229687) (← links)
- Effectiveness and safety of benralizumab for severe asthma in clinical practice (J-BEST): a prospective study (Q94571745) (← links)